Searching for balanced hybrid NO-donor 1,4-dihydropyridines with basic properties
- PMID: 11496959
- DOI: 10.1023/a:1010992412549
Searching for balanced hybrid NO-donor 1,4-dihydropyridines with basic properties
Abstract
Purpose: Model compounds containing NO-donor furoxan moieties at the 3-positioned basic lateral chain of 1, a 1,4-dihydropyridine related to nicardipine, were synthesized in order to study their vasodilating activity as well as their basic and lipophilic behaviour.
Methods: All the compounds were obtained by a modified Hantzsch approach. Potentiometry was used to determine pKa and lipophilicity descriptors. The furoxan 4-aryl-1,4-dihydropyridines were assessed for their ability to release nitrite, in the presence of a large excess of cysteine, by the Griess reaction. Vasodilating activity of the products in the absence and in the presence of ODQ, a well-known guanylate cyclase inhibitor, was evaluated on rat thoracic aorta.
Results: The compounds display low basicity values and for this reason their log Ds at physiological pH are identical to the log Ps of the neutral forms. Products 2, 3 display vasodilating action principally dependent on their Ca2+-antagonist properties, whereas 4 behaves as a well-balanced hybrid with mixed Ca2+-channel blocker and NO-dependent vasodilator activities. CONCLUSIONS. Nitrogen containing lateral chain at the 3-position of 1 is a suitable molecular region to be modified in order to obtain well-balanced furoxan NO-donor 1,4-DHPs. This manipulation produces a decrease in the basicity. General analysis of pKa and lipophilicity descriptors of these new DHPs suggest that molecular flexibility could influence both their basicity and log PI.
Similar articles
-
Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activities.Pharm Res. 2001 Feb;18(2):157-65. doi: 10.1023/a:1011072116210. Pharm Res. 2001. PMID: 11405285
-
New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.J Med Chem. 1998 Dec 31;41(27):5393-401. doi: 10.1021/jm9803267. J Med Chem. 1998. PMID: 9876109
-
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties.J Med Chem. 2004 May 6;47(10):2688-93. doi: 10.1021/jm031109v. J Med Chem. 2004. PMID: 15115410
-
1,4-Dihydropyridines--a basis for developing new drugs.Med Res Rev. 1989 Jul-Sep;9(3):291-324. doi: 10.1002/med.2610090304. Med Res Rev. 1989. PMID: 2666803 Review. No abstract available.
-
Diversified Synthetic Pathway of 1, 4-Dihydropyridines: A Class of Pharmacologically Important Molecules.Mini Rev Med Chem. 2021;21(2):135-149. doi: 10.2174/1389557520666200807130215. Mini Rev Med Chem. 2021. PMID: 32767934 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous